JOWAY HEALTH INDUSTRIES GROUP INC (GTVI) financial statements (2020 and earlier)

Company profile

Business Address NO 19 BAOWANG ROAD
TIANJIN, PRC, 300180
State of Incorp. NV
Fiscal Year End December 31
SIC 677 - Blank Checks (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1009111294119116296
Cash and cash equivalents1009111294119116296
Receivables29223733533965
Inventory, net of allowances, customer advances and progress billings500532560547532549555
Inventory500532560547532549555
Prepaid expense977401120
Advances on inventory purchases563840641193459
Other undisclosed current assets  107931026585
Total current assets:7837578578319268041,061
Noncurrent Assets
Property, plant and equipment3,3773,4293,6333,8203,7453,8624,116
Other noncurrent assets448447465480474479502
Total noncurrent assets:3,8253,8754,0984,3004,2184,3414,618
TOTAL ASSETS:4,6084,6324,9555,1315,1455,1465,679
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities92929597984577
Accounts payable92929597984577
Due to related parties1,4811,2261,189964644348257
Other liabilities56603336415862
Other undisclosed current liabilities226235711631121
Total current liabilities:1,6501,3841,3401,154899483517
Noncurrent Liabilities
Total liabilities:1,6501,3841,3401,154899483517
Stockholders' equity
Stockholders' equity attributable to parent, including:2,9583,2483,6153,9774,2454,6635,162
Common stock20202020202020
Additional paid in capital7,3627,3627,3627,3627,3627,3627,362
Accumulated other comprehensive income486443549639535543732
Accumulated deficit(5,264)(4,930)(4,670)(4,398)(4,026)(3,616)(3,306)
Other undisclosed stockholders' equity attributable to parent354354354354354354354
Total stockholders' equity:2,9583,2483,6153,9774,2454,6635,162
TOTAL LIABILITIES AND EQUITY:4,6084,6324,9555,1315,1455,1465,679

Income statement (P&L) ($ in thousands)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues140159171139192390678
Cost of revenue
(Cost of Goods and Services Sold)
(74)(70)(83)(69)(83)(163)(314)
Gross profit:67898969109227363
Operating expenses(401)(277)(361)(440)(502)(539)(704)
Operating loss:(334)(189)(272)(370)(393)(311)(341)
Nonoperating income (expense)1(72)(0)(1)(17)1(0)
Investment income, nonoperating 000000
Other nonoperating income (expense) (72)(0)(1)(17)1(0)
Net loss available to common stockholders, diluted:(334)(260)(273)(371)(410)(310)(341)

Comprehensive Income ($ in thousands)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(334)(260)(273)(371)(410)(310)(341)
Comprehensive loss:(334)(260)(273)(371)(410)(310)(341)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent43(106)(90)104(8)(189)(287)
Comprehensive loss, net of tax, attributable to parent:(290)(366)(363)(268)(418)(499)(627)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: